{"id":22214,"date":"2022-12-29T11:50:54","date_gmt":"2022-12-29T19:50:54","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=22214"},"modified":"2024-07-09T15:28:18","modified_gmt":"2024-07-09T22:28:18","slug":"xospata-gilteritinib","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/","title":{"rendered":"Xospata (Gilteritinib)"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Ung th\u01b0 l\u00e0 m\u1ed9t trong nh\u1eefng v\u1ea5n \u0111\u1ec1 s\u1ee9c kh\u1ecfe nguy hi\u1ec3m nh\u1ea5t tr\u00ean th\u1ebf gi\u1edbi. N\u00f3 t\u1ed3n t\u1ea1i d\u01b0\u1edbi nhi\u1ec1u d\u1ea1ng kh\u00e1c nhau, v\u00e0 m\u1ed9t trong s\u1ed1 \u0111\u00f3 l\u00e0 b\u1ec7nh b\u1ea1ch c\u1ea7u t\u1ee7y c\u1ea5p t\u00ednh (AML). AML l\u00e0 m\u1ed9t lo\u1ea1i ung th\u01b0 m\u00e1u, b\u1eaft ngu\u1ed3n t\u1eeb t\u1ee7y x\u01b0\u01a1ng. N\u1ebfu kh\u00f4ng \u0111\u01b0\u1ee3c \u0111i\u1ec1u tr\u1ecb k\u1ecbp th\u1eddi, lo\u1ea1i ung th\u01b0 n\u00e0y th\u01b0\u1eddng ti\u1ebfn tri\u1ec3n nhanh ch\u00f3ng. AML c\u00f2n \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 b\u1ec7nh b\u1ea1ch c\u1ea7u c\u1ea5p t\u00ednh kh\u00f4ng ph\u1ea3i lymphocytic ho\u1eb7c b\u1ec7nh b\u1ea1ch c\u1ea7u t\u1ee7y c\u1ea5p t\u00ednh.&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-a2f3290f9184eb658f42e56738457f7e\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tNh\u1eadn tr\u1ee3 gi\u00fap \u0111\u1ed3ng thanh to\u00e1n\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tN\u00f3i chuy\u1ec7n v\u1edbi m\u1ed9t chuy\u00ean gia\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">T\u1ee7y x\u01b0\u01a1ng l\u00e0 m\u1ed9t ph\u1ea7n r\u1ea5t quan tr\u1ecdng c\u1ee7a x\u01b0\u01a1ng ng\u01b0\u1eddi v\u00ec n\u00f3 ch\u1ecbu tr\u00e1ch nhi\u1ec7m s\u1ea3n xu\u1ea5t b\u1ea1ch c\u1ea7u, h\u1ed3ng c\u1ea7u v\u00e0 ti\u1ec3u c\u1ea7u trong h\u1ec7 tu\u1ea7n ho\u00e0n. Khi t\u1ee7y x\u01b0\u01a1ng b\u1ecb \u1ea3nh h\u01b0\u1edfng b\u1edfi lo\u1ea1i ung th\u01b0 n\u00e0y, t\u1ee7y x\u01b0\u01a1ng b\u1eaft \u0111\u1ea7u s\u1ea3n xu\u1ea5t c\u00e1c t\u1ebf b\u00e0o b\u1ea5t th\u01b0\u1eddng \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 t\u1ebf b\u00e0o nguy\u00ean b\u00e0o.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Theo c\u00e1c nghi\u00ean c\u1ee9u g\u1ea7n \u0111\u00e2y, AML l\u00e0 lo\u1ea1i b\u1ec7nh b\u1ea1ch c\u1ea7u ph\u1ed5 bi\u1ebfn nh\u1ea5t \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn ng\u01b0\u1eddi l\u1edbn. T\u1ea1i Hoa K\u1ef3, kho\u1ea3ng <\/span><a href=\"https:\/\/www.cancer.org\/cancer\/acute-myeloid-leukemia\/about\/key-statistics.html\"><span style=\"font-weight: 400;\">20.000 ng\u01b0\u1eddi<\/span><\/a><span style=\"font-weight: 400;\"> m\u1eafc b\u1ec7nh ung th\u01b0 n\u00e0y h\u00e0ng n\u0103m v\u00e0 m\u1eb7c d\u00f9 ph\u1ed5 bi\u1ebfn \u1edf ng\u01b0\u1eddi l\u1edbn, nh\u01b0ng n\u00f3 c\u0169ng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn nh\u1eefng ng\u01b0\u1eddi tr\u1ebb tu\u1ed5i.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">C\u00e1c lo\u1ea1i ung th\u01b0 nh\u01b0 AML c\u00f3 th\u1ec3 do \u0111\u1ed9t bi\u1ebfn l\u00e0m b\u1ea5t ho\u1ea1t gen \u1ee9c ch\u1ebf kh\u1ed1i u ho\u1eb7c k\u00edch ho\u1ea1t gen g\u00e2y ung th\u01b0. V\u00ed d\u1ee5, nh\u1eefng thay \u0111\u1ed5i \u1edf c\u00e1c gen nh\u01b0 c-KIT, FLT3 v\u00e0 RAS c\u00f3 th\u1ec3 x\u1ea3y ra trong t\u1ebf b\u00e0o AML. Nh\u1eefng thay \u0111\u1ed5i n\u00e0y c\u00f3 th\u1ec3 khi\u1ebfn c\u00e1c t\u1ebf b\u00e0o t\u1ee7y x\u01b0\u01a1ng ph\u00e1t tri\u1ec3n ngo\u00e0i t\u1ea7m ki\u1ec3m so\u00e1t ho\u1eb7c ng\u1eebng tr\u01b0\u1edfng th\u00e0nh theo c\u00e1ch b\u00ecnh th\u01b0\u1eddng.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">M\u1ed9t trong nh\u1eefng l\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb t\u1ed1t nh\u1ea5t cho b\u1ec7nh AML l\u00e0 Xospata. Trong b\u00e0i vi\u1ebft n\u00e0y, ch\u00fang ta s\u1ebd th\u1ea3o lu\u1eadn v\u1ec1 c\u00e1ch th\u1ee9c ho\u1ea1t \u0111\u1ed9ng, li\u1ec1u l\u01b0\u1ee3ng ph\u00f9 h\u1ee3p v\u00e0 t\u00e1c d\u1ee5ng ph\u1ee5 c\u1ee7a thu\u1ed1c n\u00e0y.&nbsp;<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Chuy\u1ec3n \u0111\u1ed5i m\u1ee5c l\u1ee5c\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Chuy\u1ec3n \u0111\u1ed5i<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/#What_Is_Xospata\" >Xospata l\u00e0 g\u00ec?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/#Approval_and_Efficacy\" >S\u1ef1 ch\u1ea5p thu\u1eadn v\u00e0 hi\u1ec7u qu\u1ea3<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/#Dosage\" >Li\u1ec1u d\u00f9ng<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/#Side_Effects_of_Xospata\" >T\u00e1c d\u1ee5ng ph\u1ee5 c\u1ee7a Xospata<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/#Mild_and_Common_Side_Effects\" >T\u00e1c d\u1ee5ng ph\u1ee5 nh\u1eb9 v\u00e0 ph\u1ed5 bi\u1ebfn<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/#Serious_Side_Effects\" >T\u00e1c d\u1ee5ng ph\u1ee5 nghi\u00eam tr\u1ecdng<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/#Cost\" >Tr\u1ecb gi\u00e1<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Xospata\"><\/span>Xospata l\u00e0 g\u00ec?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Xospata l\u00e0 thu\u1ed1c \u0111\u01b0\u1ee3c k\u00ea \u0111\u01a1n \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh b\u1ea1ch c\u1ea7u t\u1ee7y c\u1ea5p t\u00ednh (AML) \u1edf ng\u01b0\u1eddi l\u1edbn v\u1edbi m\u1ed9t \u0111\u1ed9t bi\u1ebfn nh\u1ea5t \u0111\u1ecbnh, \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 \u0111\u1ed9t bi\u1ebfn tyrosine kinase 3 gi\u1ed1ng FMS (FLT-3). \u0110\u1ed9t bi\u1ebfn n\u00e0y khi\u1ebfn c\u00e1c t\u1ebf b\u00e0o b\u1ea1ch c\u1ea7u ph\u00e1t tri\u1ec3n v\u00e0 ph\u00e2n chia nhanh ch\u00f3ng, l\u00e0m gi\u1ea3m c\u01a1 h\u1ed9i s\u1ea3n sinh c\u00e1c t\u1ebf b\u00e0o m\u00e1u kh\u1ecfe m\u1ea1nh.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u0110\u1ed9t bi\u1ebfn n\u00e0y c\u0169ng l\u00e0 lo\u1ea1i \u0111\u1ed9t bi\u1ebfn ph\u1ed5 bi\u1ebfn nh\u1ea5t \u1edf b\u1ec7nh nh\u00e2n AML. <\/span><a href=\"https:\/\/ashpublications.org\/blood\/article\/100\/7\/2393\/106192\/Studies-of-FLT3-mutations-in-paired-presentation#:~:text=FLT3%20mutations%2C%20either%20internal%20tandem,with%20an%20increased%20relapse%20rate.\"><span style=\"font-weight: 400;\">M\u1ed9t trong ba ng\u01b0\u1eddi<\/span><\/a><span style=\"font-weight: 400;\"> v\u1edbi AML c\u00f3 \u0111\u1ed9t bi\u1ebfn FLT-3. Vi\u1ec7c s\u1eed d\u1ee5ng Xospata \u0111\u01b0\u1ee3c th\u1ef1c hi\u1ec7n sau khi b\u1ec7nh nh\u00e2n c\u00f3 <\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-treatment-adult-patients-who-have-relapsed-or-refractory-acute-myeloid-leukemia-aml\"><span style=\"font-weight: 400;\">\u0111\u00e3 \u0111\u01b0\u1ee3c th\u1eed nghi\u1ec7m<\/span><\/a><span style=\"font-weight: 400;\"> \u0111\u1ec3 x\u00e1c \u0111\u1ecbnh s\u1ef1 hi\u1ec7n di\u1ec7n c\u1ee7a gen \u0111\u1ed9t bi\u1ebfn v\u00e0 li\u1ec7u c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb kh\u00e1c c\u00f3 hi\u1ec7u qu\u1ea3 hay kh\u00f4ng.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Xospata l\u00e0 t\u00ean th\u01b0\u01a1ng m\u1ea1i c\u1ee7a lo\u1ea1i thu\u1ed1c c\u00f3 ho\u1ea1t ch\u1ea5t l\u00e0 gilteritinib. Gilteritinib thu\u1ed9c ph\u00e2n nh\u00f3m thu\u1ed1c \u1ee9c ch\u1ebf tyrosine kinase (TKI). C\u00e1c ch\u1ea5t \u1ee9c ch\u1ebf n\u00e0y nh\u1eafm m\u1ee5c ti\u00eau v\u00e0 t\u1ea5n c\u00f4ng t\u1ebf b\u00e0o ung th\u01b0 ho\u1eb7c t\u1ebf b\u00e0o b\u1ea5t th\u01b0\u1eddng. C\u1ee5 th\u1ec3, Xospata \u1ee9c ch\u1ebf enzyme tyrosine kinase 3 gi\u1ed1ng FMS (FLT-3). Thu\u1ed1c \u0111\u01b0\u1ee3c b\u00e0o ch\u1ebf d\u01b0\u1edbi d\u1ea1ng vi\u00ean n\u00e9n 40 mg, u\u1ed1ng nguy\u00ean vi\u00ean. Kh\u00f4ng \u0111\u01b0\u1ee3c nghi\u1ec1n n\u00e1t, b\u1ebb ho\u1eb7c nhai vi\u00ean thu\u1ed1c.&nbsp;&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Approval_and_Efficacy\"><\/span>S\u1ef1 ch\u1ea5p thu\u1eadn v\u00e0 hi\u1ec7u qu\u1ea3<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">C\u1ee5c Qu\u1ea3n l\u00fd Th\u1ef1c ph\u1ea9m v\u00e0 D\u01b0\u1ee3c ph\u1ea9m (FDA) t\u1ea1i Hoa K\u1ef3 \u0111\u00e3 <\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-treatment-adult-patients-who-have-relapsed-or-refractory-acute-myeloid-leukemia-aml\"><span style=\"font-weight: 400;\">t\u00e1n th\u00e0nh<\/span><\/a><span style=\"font-weight: 400;\"> Xospata t\u1eeb n\u0103m 2018. \u0110i\u1ec1u n\u00e0y di\u1ec5n ra trong b\u1ed1i c\u1ea3nh c\u00f3 nhi\u1ec1u nghi\u00ean c\u1ee9u cho th\u1ea5y Xospata c\u00f3 t\u00e1c d\u1ee5ng \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t bi\u1ebfn FLT-3 trong b\u1ec7nh AML.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">TRONG <\/span><a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=b5ff59aa-9c0d-49a8-9053-1f179b482383\"><span style=\"font-weight: 400;\">m\u1ed9t trong nh\u1eefng nghi\u00ean c\u1ee9u n\u00e0y<\/span><\/a><span style=\"font-weight: 400;\">Hi\u1ec7u qu\u1ea3 c\u1ee7a Xospata \u0111\u00e3 \u0111\u01b0\u1ee3c so s\u00e1nh v\u1edbi c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb kh\u00e1c hi\u1ec7n c\u00f3 cho b\u1ec7nh AML. M\u1ee5c \u0111\u00edch c\u1ee7a nghi\u00ean c\u1ee9u l\u00e0 x\u00e1c \u0111\u1ecbnh ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb n\u00e0o gi\u00fap \u0111\u1ea1t \u0111\u01b0\u1ee3c s\u1ef1 thuy\u00ean gi\u1ea3m ung th\u01b0 ho\u00e0n to\u00e0n.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">V\u00e0o cu\u1ed1i nghi\u00ean c\u1ee9u, ng\u01b0\u1eddi ta ph\u00e1t hi\u1ec7n ra r\u1eb1ng 14,2% \u1edf nh\u1eefng ng\u01b0\u1eddi s\u1eed d\u1ee5ng Xospata \u0111\u00e3 \u0111\u1ea1t \u0111\u01b0\u1ee3c s\u1ef1 thuy\u00ean gi\u1ea3m tr\u00e1i ng\u01b0\u1ee3c v\u1edbi 10,5% \u1edf nh\u1eefng ng\u01b0\u1eddi s\u1eed d\u1ee5ng c\u00e1c l\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb kh\u00e1c, ch\u1eb3ng h\u1ea1n nh\u01b0 <a href=\"https:\/\/ameripharmaspecialty.com\/vi\/oral-chemotherapy-cancer-drugs\/\">h\u00f3a tr\u1ecb<\/a>Nh\u1eefng ng\u01b0\u1eddi tham gia s\u1eed d\u1ee5ng Xospata c\u0169ng duy tr\u00ec s\u1ef1 thuy\u00ean gi\u1ea3m l\u00e2u h\u01a1n v\u00e0 s\u1ed1ng l\u00e2u h\u01a1n so v\u1edbi nh\u1eefng b\u1ec7nh nh\u00e2n s\u1eed d\u1ee5ng h\u00f3a tr\u1ecb. S\u1ef1 kh\u00e1c bi\u1ec7t v\u1ec1 th\u1eddi gian thuy\u00ean gi\u1ea3m l\u00e0 13 th\u00e1ng, trong khi s\u1ef1 kh\u00e1c bi\u1ec7t v\u1ec1 tu\u1ed5i th\u1ecd l\u00e0 4 th\u00e1ng.&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-42b1b8aaa11ef29c253ce227a9ff4a10\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tN\u00f3i chuy\u1ec7n v\u1edbi chuy\u00ean gia v\u1ec1 h\u1ed7 tr\u1ee3 \u0111\u1ed3ng thanh to\u00e1n\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">L\u00ean l\u1ecbch t\u01b0 v\u1ea5n<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dosage\"><\/span>Li\u1ec1u d\u00f9ng<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"290\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata.jpg\" alt=\"Patient taking Xospata\" class=\"wp-image-22215\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata-300x207.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata-86x59.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata-167x115.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata-280x193.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata-370x255.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">Li\u1ec1u d\u00f9ng Xospata kh\u00e1c nhau cho m\u1ed7i ng\u01b0\u1eddi. \u0110i\u1ec1u n\u00e0y l\u00e0 do c\u00f3 nhi\u1ec1u y\u1ebfu t\u1ed1 quy\u1ebft \u0111\u1ecbnh li\u1ec1u d\u00f9ng ch\u00ednh x\u00e1c, v\u00e0 m\u1ed9t s\u1ed1 y\u1ebfu t\u1ed1 n\u00e0y bao g\u1ed3m c\u00e1c b\u1ec7nh l\u00fd n\u1ec1n v\u00e0 m\u1ee9c \u0111\u1ed9 nghi\u00eam tr\u1ecdng c\u1ee7a b\u1ec7nh AML.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Th\u00f4ng th\u01b0\u1eddng, b\u1ea1n s\u1ebd b\u1eaft \u0111\u1ea7u v\u1edbi li\u1ec1u th\u1ea5p, v\u00e0 d\u1ef1a v\u00e0o t\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng c\u1ee7a b\u1ea1n l\u00e0m th\u01b0\u1edbc \u0111o, b\u00e1c s\u0129 s\u1ebd \u0111i\u1ec1u ch\u1ec9nh li\u1ec1u l\u01b0\u1ee3ng. M\u1ee5c ti\u00eau l\u00e0 b\u1eaft \u0111\u1ea7u v\u1edbi li\u1ec1u th\u1ea5p nh\u1ea5t mang l\u1ea1i hi\u1ec7u qu\u1ea3 mong mu\u1ed1n nh\u1ea5t.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">N\u1ebfu b\u1ea1n b\u1eaft \u0111\u1ea7u nh\u1eadn th\u1ea5y b\u1ea5t k\u1ef3 t\u00e1c d\u1ee5ng ph\u1ee5 n\u00e0o, b\u1ea1n n\u00ean li\u00ean h\u1ec7 ngay v\u1edbi b\u00e1c s\u0129. B\u00e1c s\u0129 r\u1ea5t c\u00f3 th\u1ec3 s\u1ebd ng\u1eebng d\u00f9ng thu\u1ed1c, sau \u0111\u00f3 gi\u1ea3m li\u1ec1u \u0111\u1ec3 gi\u00fap b\u1ea1n tr\u00e1nh t\u00e1c d\u1ee5ng ph\u1ee5.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Li\u1ec1u khuy\u1ebfn c\u00e1o s\u1eed d\u1ee5ng Xospata \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh b\u1ea1ch c\u1ea7u t\u1ee7y c\u1ea5p t\u00ednh l\u00e0 120 mg. C\u00f3 th\u1ec3 gi\u1ea3m li\u1ec1u xu\u1ed1ng 80 mg n\u1ebfu b\u1eaft \u0111\u1ea7u xu\u1ea5t hi\u1ec7n t\u00e1c d\u1ee5ng ph\u1ee5. N\u1ebfu b\u1ea1n qu\u00ean li\u1ec1u \u0111\u00e3 \u0111\u1ecbnh v\u00e0 li\u1ec1u ti\u1ebfp theo v\u1eabn c\u00f2n kho\u1ea3ng 12 gi\u1edd n\u1eefa, h\u00e3y u\u1ed1ng thu\u1ed1c ngay l\u1eadp t\u1ee9c. Ng\u01b0\u1ee3c l\u1ea1i, n\u1ebfu li\u1ec1u ti\u1ebfp theo c\u00e1ch li\u1ec1u hi\u1ec7n t\u1ea1i trong v\u00f2ng 12 gi\u1edd, ch\u1ec9 c\u1ea7n ch\u1edd li\u1ec1u ti\u1ebfp theo. B\u1ea1n kh\u00f4ng \u0111\u01b0\u1ee3c u\u1ed1ng qu\u00e1 m\u1ed9t li\u1ec1u thu\u1ed1c trong v\u00f2ng 12 gi\u1edd.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Xin l\u01b0u \u00fd r\u1eb1ng thu\u1ed1c n\u00e0y \u0111\u01b0\u1ee3c thi\u1ebft k\u1ebf y khoa \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb l\u00e2u d\u00e0i. Mi\u1ec5n l\u00e0 b\u00e1c s\u0129 x\u00e1c \u0111\u1ecbnh thu\u1ed1c an to\u00e0n cho b\u1ea1n v\u00e0 b\u1ea1n kh\u00f4ng g\u1eb7p b\u1ea5t k\u1ef3 t\u00e1c d\u1ee5ng ph\u1ee5 n\u00e0o, b\u1ea1n c\u00f3 th\u1ec3 y\u00ean t\u00e2m s\u1eed d\u1ee5ng Xospata l\u00e2u d\u00e0i.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Side_Effects_of_Xospata\"><\/span>T\u00e1c d\u1ee5ng ph\u1ee5 c\u1ee7a Xospata<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">C\u00f3 m\u1ed9t s\u1ed1 t\u00e1c d\u1ee5ng ph\u1ee5 nh\u1eb9 v\u00e0 nghi\u00eam tr\u1ecdng c\u00f3 th\u1ec3 ph\u00e1t sinh khi s\u1eed d\u1ee5ng Xospata. L\u01b0u \u00fd r\u1eb1ng c\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 \u0111\u01b0\u1ee3c \u0111\u1ec1 c\u1eadp d\u01b0\u1edbi \u0111\u00e2y kh\u00f4ng \u0111\u1ea1i di\u1ec7n cho t\u1ea5t c\u1ea3 c\u00e1c ph\u1ea3n \u1ee9ng ti\u1ec1m \u1ea9n li\u00ean quan \u0111\u1ebfn vi\u1ec7c s\u1eed d\u1ee5ng thu\u1ed1c.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">V\u00ec v\u1eady, \u0111i\u1ec1u quan tr\u1ecdng l\u00e0 b\u1ea1n ph\u1ea3i trao \u0111\u1ed5i v\u1edbi b\u00e1c s\u0129 ho\u1eb7c d\u01b0\u1ee3c s\u0129 \u0111\u1ec3 hi\u1ec3u r\u00f5 h\u01a1n v\u1ec1 t\u1ea5t c\u1ea3 c\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 li\u00ean quan \u0111\u1ebfn vi\u1ec7c s\u1eed d\u1ee5ng lo\u1ea1i thu\u1ed1c n\u00e0y.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mild_and_Common_Side_Effects\"><\/span>T\u00e1c d\u1ee5ng ph\u1ee5 nh\u1eb9 v\u00e0 ph\u1ed5 bi\u1ebfn<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">M\u1ed9t s\u1ed1 t\u00e1c d\u1ee5ng ph\u1ee5 ph\u1ed5 bi\u1ebfn m\u00e0 b\u1ea1n c\u00f3 th\u1ec3 g\u1eb7p ph\u1ea3i khi s\u1eed d\u1ee5ng Xospata bao g\u1ed3m:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">M\u1ec7t m\u1ecfi<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u0110au kh\u1edbp v\u00e0 c\u01a1<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Huy\u1ebft \u00e1p th\u1ea5p<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Ph\u00f9 n\u1ec1<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">S\u1ed1t<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Ti\u00eau ch\u1ea3y<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">C\u00e1c v\u1ebft lo\u00e9t ho\u1eb7c s\u01b0ng t\u1ea5y trong mi\u1ec7ng<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">T\u00e1o b\u00f3n<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">T\u0103ng n\u1ed3ng \u0111\u1ed9 men gan<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Ph\u00e1t ban da<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Kh\u00f3 th\u1edf<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Ch\u00f3ng m\u1eb7t<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">N\u00f4n m\u1eeda&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Bu\u1ed3n n\u00f4n<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Nh\u1eefng t\u00e1c d\u1ee5ng ph\u1ee5 n\u00e0y \u0111\u01b0\u1ee3c ph\u00e2n lo\u1ea1i l\u00e0 nh\u1eb9 ho\u1eb7c ph\u1ed5 bi\u1ebfn v\u00ec ch\u00fang th\u01b0\u1eddng bi\u1ebfn m\u1ea5t sau v\u00e0i ng\u00e0y ho\u1eb7c v\u00e0i tu\u1ea7n. Tuy nhi\u00ean, n\u1ebfu ch\u00fang k\u00e9o d\u00e0i ho\u1eb7c tr\u1edf n\u00ean nghi\u00eam tr\u1ecdng, b\u1ea1n n\u00ean n\u00f3i chuy\u1ec7n v\u1edbi b\u00e1c s\u0129.&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-6ecd5e490506bf2fc7c4454343d8d1be\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tH\u1ecfi chuy\u00ean gia v\u1ec1 t\u00e1c d\u1ee5ng ph\u1ee5\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Serious_Side_Effects\"><\/span>T\u00e1c d\u1ee5ng ph\u1ee5 nghi\u00eam tr\u1ecdng<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 sau \u0111\u00e2y kh\u00f4ng ph\u1ed5 bi\u1ebfn v\u00e0 b\u1ea1n n\u00ean t\u00ecm ki\u1ebfm s\u1ef1 tr\u1ee3 gi\u00fap y t\u1ebf ho\u1eb7c g\u1ecdi 911 ngay sau khi b\u1ea1n b\u1eaft \u0111\u1ea7u g\u1eb7p ph\u1ea3i c\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 n\u00e0y:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Vi\u00eam t\u1ee5y<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">S\u01b0ng n\u00e3o, c\u00f2n \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 h\u1ed9i ch\u1ee9ng b\u1ec7nh n\u00e3o sau c\u00f3 th\u1ec3 h\u1ed3i ph\u1ee5c<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Nh\u1ecbp tim b\u1ea5t th\u01b0\u1eddng&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">S\u1ef1 bi\u1ec7t h\u00f3a t\u1ebf b\u00e0o, m\u1ed9t t\u00ecnh tr\u1ea1ng trong \u0111\u00f3 c\u00e1c t\u1ebf b\u00e0o thay \u0111\u1ed5i v\u00e0 ph\u00e1t tri\u1ec3n v\u1ec1 s\u1ed1 l\u01b0\u1ee3ng. M\u1ed9t s\u1ed1 tri\u1ec7u ch\u1ee9ng bao g\u1ed3m t\u0103ng c\u00e2n \u0111\u1ed9t ng\u1ed9t, s\u1ed1t, c\u00e1c d\u1ea5u hi\u1ec7u c\u1ee7a b\u1ec7nh th\u1eadn, kh\u00f3 th\u1edf v\u00e0 huy\u1ebft \u00e1p th\u1ea5p. B\u00e1c s\u0129 c\u00f3 th\u1ec3 t\u1ea1m d\u1eebng Xospata n\u1ebfu c\u00e1c d\u1ea5u hi\u1ec7u v\u00e0 tri\u1ec7u ch\u1ee9ng v\u1eabn c\u00f2n dai d\u1eb3ng, v\u00e0 ti\u1ebfp t\u1ee5c \u0111i\u1ec1u tr\u1ecb khi c\u00e1c d\u1ea5u hi\u1ec7u v\u00e0 tri\u1ec7u ch\u1ee9ng c\u1ea3i thi\u1ec7n.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span>Tr\u1ecb gi\u00e1<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">S\u1ed1 ti\u1ec1n b\u1ea1n ph\u1ea3i tr\u1ea3 \u0111\u1ec3 mua Xospata ph\u1ee5 thu\u1ed9c v\u00e0o nhi\u1ec1u y\u1ebfu t\u1ed1. M\u1ed9t s\u1ed1 y\u1ebfu t\u1ed1 bao g\u1ed3m nh\u00e0 cung c\u1ea5p d\u1ecbch v\u1ee5 ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe, g\u00f3i b\u1ea3o hi\u1ec3m c\u1ee7a b\u1ea1n, hi\u1ec7u thu\u1ed1c b\u1ea1n s\u1eed d\u1ee5ng v\u00e0 v\u1ecb tr\u00ed c\u1ee7a b\u1ea1n. V\u00ec chi ph\u00ed kh\u00e1c nhau t\u00f9y theo t\u1eebng ng\u01b0\u1eddi, h\u00e3y li\u00ean h\u1ec7 v\u1edbi hi\u1ec7u thu\u1ed1c \u0111\u1ec3 bi\u1ebft gi\u00e1 m\u1edbi nh\u1ea5t.&nbsp;<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Ung th\u01b0 l\u00e0 m\u1ed9t trong nh\u1eefng v\u1ea5n \u0111\u1ec1 s\u1ee9c kh\u1ecfe nguy hi\u1ec3m nh\u1ea5t tr\u00ean th\u1ebf gi\u1edbi. N\u00f3 t\u1ed3n t\u1ea1i d\u01b0\u1edbi nhi\u1ec1u d\u1ea1ng kh\u00e1c nhau, v\u00e0 m\u1ed9t trong s\u1ed1 \u0111\u00f3 l\u00e0 b\u1ec7nh b\u1ea1ch c\u1ea7u t\u1ee7y c\u1ea5p t\u00ednh (AML). AML l\u00e0 m\u1ed9t lo\u1ea1i ung th\u01b0 m\u00e1u, b\u1eaft ngu\u1ed3n t\u1eeb t\u1ee7y x\u01b0\u01a1ng.<\/p>","protected":false},"author":21,"featured_media":22216,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[27],"class_list":["post-22214","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-dr-abdelaziz-alsamarah"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Xospata (Gilteritinib) - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Xospata is a drug prescribed for the treatment of acute myeloid leukemia. Learn about the dosage, side effects, and efficacy of this drug.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xospata (Gilteritinib) - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Xospata is a drug prescribed for the treatment of acute myeloid leukemia. Learn about the dosage, side effects, and efficacy of this drug.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-29T19:50:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-09T22:28:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/\"},\"author\":{\"name\":\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#\\\/schema\\\/person\\\/2f73858b25c20aa6bf5b731fd4e593c4\"},\"headline\":\"Xospata (Gilteritinib)\",\"datePublished\":\"2022-12-29T19:50:54+00:00\",\"dateModified\":\"2024-07-09T22:28:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/\"},\"wordCount\":1085,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Xospata-Gilteritinib.jpg\",\"keywords\":[\"Dr. Abdelaziz Alsamarah\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"vi\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/\",\"name\":\"Xospata (Gilteritinib) - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Xospata-Gilteritinib.jpg\",\"datePublished\":\"2022-12-29T19:50:54+00:00\",\"dateModified\":\"2024-07-09T22:28:18+00:00\",\"description\":\"Xospata is a drug prescribed for the treatment of acute myeloid leukemia. Learn about the dosage, side effects, and efficacy of this drug.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Xospata-Gilteritinib.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Xospata-Gilteritinib.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Doctor diagnosing condition that is treated with Xospata\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xospata (Gilteritinib)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#\\\/schema\\\/person\\\/2f73858b25c20aa6bf5b731fd4e593c4\",\"name\":\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g\",\"caption\":\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\"},\"description\":\"Dr. Alsamarah received his PharmD degree from the University of Jordan in 2011. In pursuit of higher education, he joined Western University of Health Sciences, Pomona, CA in 2014 and received a masters in pharmaceutical sciences with major in Computer-Aided Drug Design (CADD). He has authored and co-authored several publications in major scientific journals. After graduation, Dr. Alsamarah worked in various pharmacy settings before he found his passion in managing patients on IV infusions. His specialty areas include: Infectious diseases, nutrition support, and monoclonal antibodies. In his free time, he likes boxing, biking, and painting with his three kids.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/author\\\/abdelaziz\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xospata (Gilteritinib) - Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t AmeriPharma\u00ae","description":"Xospata l\u00e0 thu\u1ed1c \u0111\u01b0\u1ee3c k\u00ea \u0111\u01a1n \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh b\u1ea1ch c\u1ea7u t\u1ee7y c\u1ea5p t\u00ednh. T\u00ecm hi\u1ec3u v\u1ec1 li\u1ec1u d\u00f9ng, t\u00e1c d\u1ee5ng ph\u1ee5 v\u00e0 hi\u1ec7u qu\u1ea3 c\u1ee7a thu\u1ed1c n\u00e0y.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/","og_locale":"vi_VN","og_type":"article","og_title":"Xospata (Gilteritinib) - AmeriPharma\u00ae Specialty Care","og_description":"Xospata is a drug prescribed for the treatment of acute myeloid leukemia. Learn about the dosage, side effects, and efficacy of this drug.","og_url":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/xospata-gilteritinib\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2022-12-29T19:50:54+00:00","article_modified_time":"2024-07-09T22:28:18+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg","type":"image\/jpeg"}],"author":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","Est. reading time":"5 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/"},"author":{"name":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#\/schema\/person\/2f73858b25c20aa6bf5b731fd4e593c4"},"headline":"Xospata (Gilteritinib)","datePublished":"2022-12-29T19:50:54+00:00","dateModified":"2024-07-09T22:28:18+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/"},"wordCount":1085,"publisher":{"@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg","keywords":["Dr. Abdelaziz Alsamarah"],"articleSection":["Cancer"],"inLanguage":"vi"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/","name":"Xospata (Gilteritinib) - Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t AmeriPharma\u00ae","isPartOf":{"@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg","datePublished":"2022-12-29T19:50:54+00:00","dateModified":"2024-07-09T22:28:18+00:00","description":"Xospata l\u00e0 thu\u1ed1c \u0111\u01b0\u1ee3c k\u00ea \u0111\u01a1n \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh b\u1ea1ch c\u1ea7u t\u1ee7y c\u1ea5p t\u00ednh. T\u00ecm hi\u1ec3u v\u1ec1 li\u1ec1u d\u00f9ng, t\u00e1c d\u1ee5ng ph\u1ee5 v\u00e0 hi\u1ec7u qu\u1ea3 c\u1ee7a thu\u1ed1c n\u00e0y.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/"]}]},{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg","width":1280,"height":853,"caption":"Doctor diagnosing condition that is treated with Xospata"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspe.wpenginepowered.com\/es\/"},{"@type":"ListItem","position":2,"name":"Xospata (Gilteritinib)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#website","url":"https:\/\/ameripharmaspe.wpenginepowered.com\/","name":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t AmeriPharma\u00ae","description":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t c\u1ee7a AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspe.wpenginepowered.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Organization","@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#organization","name":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t Ameripharma","url":"https:\/\/ameripharmaspe.wpenginepowered.com\/","logo":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#\/schema\/person\/2f73858b25c20aa6bf5b731fd4e593c4","name":"Ti\u1ebfn s\u0129 Abdelaziz Alsamarah, D\u01b0\u1ee3c s\u0129, MSPS, BCSCP","image":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/secure.gravatar.com\/avatar\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g","caption":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP"},"description":"Ti\u1ebfn s\u0129 Alsamarah nh\u1eadn b\u1eb1ng Ti\u1ebfn s\u0129 D\u01b0\u1ee3c t\u1ea1i \u0110\u1ea1i h\u1ecdc Jordan n\u0103m 2011. \u0110\u1ec3 theo \u0111u\u1ed5i con \u0111\u01b0\u1eddng h\u1ecdc v\u1ea5n cao h\u01a1n, \u00f4ng gia nh\u1eadp \u0110\u1ea1i h\u1ecdc Khoa h\u1ecdc Y t\u1ebf Western, Pomona, California n\u0103m 2014 v\u00e0 nh\u1eadn b\u1eb1ng Th\u1ea1c s\u0129 Khoa h\u1ecdc D\u01b0\u1ee3c ph\u1ea9m chuy\u00ean ng\u00e0nh Thi\u1ebft k\u1ebf Thu\u1ed1c H\u1ed7 tr\u1ee3 M\u00e1y t\u00ednh (CADD). \u00d4ng l\u00e0 t\u00e1c gi\u1ea3 v\u00e0 \u0111\u1ed3ng t\u00e1c gi\u1ea3 c\u1ee7a m\u1ed9t s\u1ed1 \u1ea5n ph\u1ea9m tr\u00ean c\u00e1c t\u1ea1p ch\u00ed khoa h\u1ecdc l\u1edbn. Sau khi t\u1ed1t nghi\u1ec7p, Ti\u1ebfn s\u0129 Alsamarah \u0111\u00e3 l\u00e0m vi\u1ec7c t\u1ea1i nhi\u1ec1u c\u01a1 s\u1edf d\u01b0\u1ee3c ph\u1ea9m kh\u00e1c nhau tr\u01b0\u1edbc khi t\u00ecm th\u1ea5y ni\u1ec1m \u0111am m\u00ea trong vi\u1ec7c qu\u1ea3n l\u00fd b\u1ec7nh nh\u00e2n truy\u1ec1n d\u1ecbch t\u0129nh m\u1ea1ch. C\u00e1c l\u0129nh v\u1ef1c chuy\u00ean m\u00f4n c\u1ee7a \u00f4ng bao g\u1ed3m: B\u1ec7nh truy\u1ec1n nhi\u1ec5m, h\u1ed7 tr\u1ee3 dinh d\u01b0\u1ee1ng v\u00e0 kh\u00e1ng th\u1ec3 \u0111\u01a1n d\u00f2ng. Trong th\u1eddi gian r\u1ea3nh r\u1ed7i, \u00f4ng th\u00edch \u0111\u1ea5m b\u1ed1c, \u0111\u1ea1p xe v\u00e0 v\u1ebd tranh c\u00f9ng ba con.","url":"https:\/\/ameripharmaspecialty.com\/vi\/author\/abdelaziz\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","author_link":"https:\/\/ameripharmaspecialty.com\/vi\/author\/abdelaziz\/"},"uagb_comment_info":1,"uagb_excerpt":"Cancer is one of the most deadly health issues in the world. It exists in many different forms, and one of these forms is acute myeloid leukemia (AML). AML is a type of blood cancer, and it originates from the bone marrow.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","author_link":"https:\/\/ameripharmaspecialty.com\/vi\/author\/abdelaziz\/"},"rttpg_comment":1,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/vi\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Cancer is one of the most deadly health issues in the world. It exists in many different forms, and one of these forms is acute myeloid leukemia (AML). AML is a type of blood cancer, and it originates from the bone marrow.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts\/22214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/comments?post=22214"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts\/22214\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/media\/22216"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/media?parent=22214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/categories?post=22214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/tags?post=22214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}